Michael Millenson
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 40
- Viral-associated cancers and disorders 17
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 6
-
- Lymphoma Diagnosis and Treatment 38
- Co-authors
- Scott J. Rodig (3 shared papers)Philippe Armand (3 shared papers)Li Zhu (3 shared papers)Ahmad Halwani (3 shared papers)Bjoern Chapuy (2 shared papers)Alexander M. Lesokhin (2 shared papers)Margaret A. Shipp (2 shared papers)Emma C. Scott (2 shared papers)
- Journals
- Blood (17 papers)Journal of Clinical Oncology (7 papers)Cancer (6 papers)Journal of Thoracic Oncology (5 papers)Journal of the National Comprehensive Cancer Network (4 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Michael Millenson
64 papers receiving 4.4k citations
Michael Millenson's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 3.0k
- Pathology and Forensic Medicine 2.0k
- Genetics 747
- Immunology 1.4k
- Neurology 619
Countries citing papers authored by Michael Millenson
This map shows the geographic impact of Michael Millenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Millenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Millenson more than expected).
Fields of papers citing papers by Michael Millenson
This network shows the impact of papers produced by Michael Millenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Millenson. The network helps show where Michael Millenson may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Millenson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma Hit paper breakdown → | 2014 | 2663 |
| 2 | An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era Hit paper breakdown → | 2013 | 609 |
| 3 | 2012 | 171 | |
| 4 | 2011 | 66 | |
| 5 | 2008 | 64 | |
| 6 | 2012 | 63 | |
| 7 | 2017 | 52 | |
| 8 | 2013 | 49 | |
| 9 | 2013 | 47 | |
| 10 | 2005 | 46 | |
| 11 | 2008 | 42 | |
| 12 | 2003 | 36 | |
| 13 | 2014 | 34 | |
| 14 | 2006 | 33 | |
| 15 | 2013 | 32 | |
| 16 | 2002 | 32 | |
| 17 | 2007 | 31 | |
| 18 | 2014 | 27 | |
| 19 | 2011 | 26 | |
| 20 | NCCN Practice Guidelines for Acute Myelogenous Leukemia. | 2000 | 25 |
About Michael Millenson
Michael Millenson is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Genetics and Neurology, having authored 64 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (17 papers), Lung Cancer Treatments and Mutations (16 papers), Chronic Lymphocytic Leukemia Research (12 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Oncology (3.0k citations), Pathology and Forensic Medicine (2.0k citations), Genetics (747 citations), Immunology (1.4k citations) and Neurology (619 citations). Michael Millenson has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Scott J. Rodig, Philippe Armand, Li Zhu, Ahmad Halwani, Bjoern Chapuy, Alexander M. Lesokhin, Margaret A. Shipp, Emma C. Scott, Stephen M. Ansell and Ivan Borrello. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Journal of Thoracic Oncology and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.